162 related articles for article (PubMed ID: 24175265)
21. Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients. Durham Renal Osteodystrophy Study Group.
Indridason OS; Quarles LD
Kidney Int; 2000 Jan; 57(1):282-92. PubMed ID: 10620210
[TBL] [Abstract][Full Text] [Related]
22. Hypercalcemia and lipoid pneumonia.
Greenaway TM; Caterson ID
Aust N Z J Med; 1989 Dec; 19(6):713-5. PubMed ID: 2631665
[TBL] [Abstract][Full Text] [Related]
23. Granulomatous slack skin mycosis fungoides developing simultaneously with sarcoid-like lesions in a patient with repeated anabolic injections in the past?
Tchernev G; Patterson JW; Wollina U; Lotti T; Temelkova I
Dermatol Ther; 2020 Jan; 33(1):e13200. PubMed ID: 31854482
[TBL] [Abstract][Full Text] [Related]
24. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
25. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma.
Seymour JF; Gagel RF; Hagemeister FB; Dimopoulos MA; Cabanillas F
Ann Intern Med; 1994 Nov; 121(9):633-40. PubMed ID: 7944070
[TBL] [Abstract][Full Text] [Related]
26. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
Falk S; Kratzsch J; Paschke R; Koch CA
Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303
[TBL] [Abstract][Full Text] [Related]
27. Hyperphosphatemia modestly retards parathyroid hormone suppression during calcitriol-induced hypercalcemia in normal and azotemic rats.
Jara A; Chacón C; Felsenfeld AJ
Nephron; 2002 Dec; 92(4):883-8. PubMed ID: 12399635
[TBL] [Abstract][Full Text] [Related]
28. The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients.
Rodriguez M; Felsenfeld AJ; Williams C; Pederson JA; Llach F
J Am Soc Nephrol; 1991 Nov; 2(5):1014-20. PubMed ID: 1760537
[TBL] [Abstract][Full Text] [Related]
29. Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD.
Quarles LD; Yohay DA; Carroll BA; Spritzer CE; Minda SA; Bartholomay D; Lobaugh BA
Kidney Int; 1994 Jun; 45(6):1710-21. PubMed ID: 7933819
[TBL] [Abstract][Full Text] [Related]
30. Hypercalcemia in hyperthyroidism: patterns of serum calcium, parathyroid hormone, and 1,25-dihydroxyvitamin D3 levels during management of thyrotoxicosis.
Iqbal AA; Burgess EH; Gallina DL; Nanes MS; Cook CB
Endocr Pract; 2003; 9(6):517-21. PubMed ID: 14715479
[TBL] [Abstract][Full Text] [Related]
31. 'Pulse oral' versus intravenous calcitriol therapy in chronic hemodialysis patients. A prospective and randomized study.
Bacchini G; Fabrizi F; Pontoriero G; Marcelli D; Di Filippo S; Locatelli F
Nephron; 1997; 77(3):267-72. PubMed ID: 9375818
[TBL] [Abstract][Full Text] [Related]
32. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM
Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244
[TBL] [Abstract][Full Text] [Related]
33. Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.
Rauscher S; Lafrance JP; Pichette V; Bell RZ; Desforges K; Lepage L; Ouellet G; Ouimet D; Leblanc M; Lamarche C; Bezzaoucha S; Vallee M
Int Urol Nephrol; 2017 Feb; 49(2):325-328. PubMed ID: 27822674
[TBL] [Abstract][Full Text] [Related]
34. Intramuscular calcitriol for uraemic children with severe hyperparathyroidism and hypercalcaemia.
Claris-Appiani A; Ardissino GL; Tischer MC; Bettinelli A; Tirelli AS; Daccò V; Castiglioni G; Pecchio F; Cunazza M; Assael BM
Pediatr Nephrol; 1994 Dec; 8(6):719-23. PubMed ID: 7696112
[TBL] [Abstract][Full Text] [Related]
35. Calcitriol induced hypercalcemia - a rare phenomenon in lung cancer: A case report.
Prakash A; Khalid F; Alalwan A; Bader H; Du D; Meghal T
World J Clin Oncol; 2023 Nov; 14(11):544-548. PubMed ID: 38059187
[TBL] [Abstract][Full Text] [Related]
36. Liver granulomatosis is not an exceptional cause of hypercalcemia with hypoparathyroidism in dialysis patients.
Hardy P; Morinière PH; Tribout B; Hamdini N; Marié A; Bouffandeau B; Pruna A; Fournier A
J Nephrol; 1999; 12(6):398-403. PubMed ID: 10626831
[TBL] [Abstract][Full Text] [Related]
37. A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients.
Delmez JA; Kelber J; Norwood KY; Giles KS; Slatopolsky E
Clin Nephrol; 2000 Oct; 54(4):301-8. PubMed ID: 11076106
[TBL] [Abstract][Full Text] [Related]
38. Hypercalcemia associated with Wegener's granulomatosis and hyperparathyroidism: etiology and management.
Edelson GW; Talpos GB; Bone HG
Am J Nephrol; 1993; 13(4):275-7. PubMed ID: 8267026
[TBL] [Abstract][Full Text] [Related]
39. A Rare Case of Extra-Pulmonary Sarcoidosis With Only Initial Presentation of Hypercalcemia.
Surpur S; Singh A; Webb J
Cureus; 2023 Sep; 15(9):e45100. PubMed ID: 37842373
[TBL] [Abstract][Full Text] [Related]
40. An unusual case of mycosis fungoides presenting as sarcoidosis or granulomatous mycosis fungoides.
Mainguene C; Picard O; Audouin J; Le Tourneau A; Jagueux M; Diebold J
Am J Clin Pathol; 1993 Jan; 99(1):82-6. PubMed ID: 8422022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
